This company seems to have been delisted
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
ChemoCentryx
CCXI
$72.55
Share price
0.00%
Change (1 day)
37.49%
Change (1 year)
Categories
EPS for ChemoCentryx (CCXI)
EPS in 2022 (TTM): -$2.40
According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is -$2.64. In 2021 the company made an earnings per share (EPS) of -$2.64 a decrease over its 2020 EPS that were of -$1.13.
EPS history for ChemoCentryx from 2012 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | -$2.40 | -8.98% |
| 2021 | -$2.64 | 133.33% |
| 2020 | -$1.13 | -16.49% |
| 2019 | -$1.35 | 27.63% |
| 2018 | -$1.06 | -305.41% |
| 2017 | $0.52 | -142.53% |
| 2016 | -$1.21 | -19.44% |
| 2015 | -$1.51 | -0% |
| 2014 | -$1.51 | 13.68% |
| 2013 | -$1.33 | -16.67% |
| 2012 | -$1.59 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | $25.76 | -1,076.72% | 🇺🇸 USA |
 | $5.14 | -294.74% | 🇺🇸 USA |
 | $4.89 | -285.22% | 🇬🇧 UK |
 | $5.54 | -310.05% | 🇺🇸 USA |
 | $19.66 | -845.25% | 🇺🇸 USA |
 | $19.75 | -848.68% | 🇺🇸 USA |
 | $2.60 | -198.41% | 🇺🇸 USA |
 | -$2.79 | 5.82% | 🇮🇱 Israel |
 | $2.54 | -196.39% | 🇺🇸 USA |